English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1157]
News [2523]
Articles [155]
Editorials [8]
Conferences [103]
elearning [18]
Cancer drug restores immune system’s ability to fight tumours
Cancer drug restores immune system’s ability to fight tumours
Targeting certain molecular interactions could yield new strategies for treating prostate cancer
Targeting certain molecular interactions could yield new strategies for treating prostate cancer
Men with metastatic prostate cancer live longer thanks to new drugs
Men with metastatic prostate cancer live longer thanks to new drugs
ASTRO 2023: High-dose radiation offers new treatment option for older patients with inoperable kidney tumours
ASTRO 2023: High-dose radiation offers new treatment option for older patients with inoperable kidney tumours
ASTRO 2023: Precision medicine navigators increase genomic testing rates for Black patients with prostate cancer
ASTRO 2023: Precision medicine navigators increase genomic testing rates for Black patients with prostate cancer
Study offers way to increase immune checkpoint inhibitor effectiveness in patients with MTAP-deleted cancers
Study offers way to increase immune checkpoint inhibitor effectiveness in patients with MTAP-deleted cancers
Genetic code of rare kidney cancer cracked
Genetic code of rare kidney cancer cracked
Mutations in 11 genes associated with aggressive prostate cancer identified in new research
Mutations in 11 genes associated with aggressive prostate cancer identified in new research
Study details immune cells vital to success of vaccines against coronavirus
Study details immune cells vital to success of vaccines against coronavirus
Prostate cancer upgrade, downgrade rates in PI-RADS 2.0 versus 2.1
Prostate cancer upgrade, downgrade rates in PI-RADS 2.0 versus 2.1
<1...2627282930...253>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top